本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cadrenal Therapeutics, Inc.

1.08
+0.03002.86%
成交量:2.25萬
成交額:2.36萬
市值:385.30萬
市盈率:-0.22
高:1.09
開:1.05
低:1.01
收:1.05
52周最高:14.64
52周最低:1.00
股本:356.76萬
流通股本:322.30萬
量比:0.91
換手率:0.70%
股息:- -
股息率:- -
每股收益(TTM):-4.8667
每股收益(LYR):-6.6394
淨資產收益率:-275.16%
總資產收益率:-125.93%
市淨率:0.94
市盈率(LYR):-0.16

資料載入中...

2025/10/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/24

重要事件披露

Form 8-K - Current report
2025/09/15

重要事件披露

Form 8-K - Current report
2025/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/11

重要事件披露

Form 8-K - Current report
2025/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report